Elizabethkingia bruuniana Infections in Humans, Taiwan, 2005-2017

Emerg Infect Dis. 2019 Jul;25(7):1412-1414. doi: 10.3201/eid2507.180768.

Abstract

Using 16S rRNA and rpoB gene sequencing, we identified 6 patients infected with Elizabethkingia bruuniana treated at E-Da Hospital (Kaohsiung, Taiwan) during 2005-2017. We describe patient characteristics and the molecular characteristics of the E. bruuniana isolates, including their MICs. Larger-scale studies are needed for more robust characterization of this pathogen.

Keywords: 16S rRNA; DNA–DNA hybridization; Elizabethkingia; Elizabethkingia bruuniana; Taiwan; antimicrobial resistance; antimicrobial susceptibility; average nucleotide identity; bacteria; clinical characteristics; drug susceptibility; fluoroquinolone resistance; phylogeny; quinolone resistance–determining regions; rpoB.

Publication types

  • Historical Article
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology
  • DNA-Directed RNA Polymerases / genetics
  • Female
  • Flavobacteriaceae Infections / epidemiology*
  • Flavobacteriaceae Infections / history
  • Flavobacteriaceae Infections / microbiology*
  • Flavobacteriaceae* / classification
  • Flavobacteriaceae* / drug effects
  • Flavobacteriaceae* / genetics
  • History, 21st Century
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Phylogeny
  • RNA, Ribosomal, 16S / genetics
  • Sequence Analysis, DNA
  • Taiwan / epidemiology

Substances

  • Anti-Bacterial Agents
  • RNA, Ribosomal, 16S
  • DNA-Directed RNA Polymerases